Logo

Thermo Fisher Scientific

Life Sciences Tools Firms, Observers Sound Alarm on Near-Term China Business Outlook
Premium

Business in China is not going as well as expected for many US companies, especially those selling sequencing- and mass spec-related research tools.

Lack of Standardization Across MDx Infectious Disease Tests Could Undermine Pandemic Preparedness
Premium

Poor cross-compatibility may make it difficult to substitute components of automated sample processing and testing workflows in the case of shortages.

Thermo Fisher Scientific to Promote Devyser Laboratory Services for Pharma Research

The companies will work together to market Devyser Diagnostics' CLIA-certified lab services to pharmaceutical companies for research and development projects.

In Brief This Week: Guardant Health, Devyser, Thermo Fisher, Flatiron Health, ERS Genomics, More

News items for the week of Sept. 4, 2023

New Products Posted to GenomeWeb: Thermo Fisher Scientific, Roche, Maine Molecular Quality Controls

New products and services posted to GenomeWeb for the week of Aug. 21, 2023

Aug 18, 2023

In Brief This Week: Illumina, Thermo Fisher, Tempus, Bionano Genomics, Danaher, More

Aug 8, 2023

Thermo Fisher Scientific Prices $2.95B Senior Notes Offering

Jul 26, 2023

Thermo Fisher Plans $450M Cost Reduction, Lowers 2023 Financial Guidance
Premium

Jul 17, 2023

Devyser Receives IVDR Certification for Kidney, Stem Cell Transplant Monitoring NGS Tests

Jul 14, 2023

People in the News at Thermo Fisher, Oxford Nanopore, Biocept, Element Biosciences, More

Jul 14, 2023

New Products Posted to GenomeWeb: ChromaCode NSCLC Assay, Thermo Fisher Diomni Software, More

Jul 14, 2023

In Brief This Week: DermTech, T2 Biosystems, Cofactor Genomics, Bio-Techne, Lunaphore, More

Jul 7, 2023

In Brief This Week: Thermo Fisher Scientific, Guardant Health, Cardio Diagnostics, PBD Biotech

Jul 6, 2023

New Instrument Releases, Workflow Development Driving Uptake of DIA Mass Spec in Proteomics
Premium

Jun 21, 2023

Recent Tech Advancements Provide Large Leap Forward for Mass Spec-Based Plasma Proteomics
Premium

Jun 9, 2023

New Products Posted to GenomeWeb: ASMS Roundup, Bionano Genomics, Parse Biosciences, BioEcho

Jun 9, 2023

In Brief This Week: HTG Molecular, Prenetics, DiaSorin, DermTech, NanoString Technologies, More

Jun 6, 2023

ASMS Sees Launch of New High-End Mass Spec Systems From Thermo Fisher, Bruker
Premium

May 26, 2023

In Brief This Week: Enzo Biochem, Eurobio Scientific, Thermo Fisher, TeselaGen, NinthBio, More

May 9, 2023

Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets

Apr 26, 2023

Thermo Fisher Q1 Revenues Down 9 Percent Due to Shrinking Pandemic Business

Apr 24, 2023

Thermo Fisher to Commercialize Devyser Post-Transplant NGS Tests in Europe, North America

Apr 18, 2023

OpGen, Fisher Healthcare Ink Distribution Deal for Unyvero MDx System

Apr 18, 2023

Thermo Fisher Launching Broad PCR Test Menu Through GeneProof Partnership
Premium

Mar 24, 2023

Cancer Sequencing Panel Speeds Rapidly Improving, but Clinical Impact Studies Are Needed
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.